Beyond Air Accelerates LungFit™ BRO COVID-19 Program

Mar 18, 2020 8:30am EDT

Beyond Air Submits Investigational Device Exemption (IDE) to the United States Food and Drug Administration (FDA) for the Treatment of COVID-19 Patients

Mar 16, 2020 8:00am EDT

Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET

Mar 05, 2020 9:00am EST

Beyond Air Hosting Analyst Day on March 5, 2020

Feb 25, 2020 8:30am EST

Beyond Air Reports Financial Results for Fiscal Third Quarter 2020

Feb 07, 2020 8:30am EST

Beyond AirTM Schedules Third Fiscal Quarter 2020 Financial Results Conference Call and Webcast

Jan 22, 2020 8:00am EST

Beyond Air Terminates Commercial Licensing Agreement for LungFit™ PH for Use in the Hospital Setting in the United States and China

Dec 18, 2019 4:03pm EST

Beyond Air, Inc. Announces Closing of $11.5 Million Public Offering and Private Placement of Common Stock and Exercise of Option to Purchase Additional Shares

Dec 12, 2019 4:15pm EST

Beyond Air Prices $10.5 Million Underwritten Offering of Common Stock and Concurrent Private Placement

Dec 10, 2019 9:12am EST

Beyond Air Announces Proposed Public Offering and Concurrent Private Placement

Dec 09, 2019 5:12pm EST